That's important, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (jeff brown top biotech 2020). Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. This was a development practically no one saw. But it's going to have extensive implications for curing illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment opportunities in this area, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (genetic sequencer stock jeff brown). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps considerably prior to going greater - tech stocks. I've been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. But that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown predictions for 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of excellent private business on the brink of striking the general public markets And I've been working on a brand-new way for you to invest even before these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to book your spot for totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our normal beat (bleeding edge). And when it concerns tech investing, we leave it to the specialists. Luckily, we have several such experts in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we understand (exponential growth). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential growth and developing extraordinary chances for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. black sea. But despite what lots of readers might believe, this is a trend that's simply getting going. Although the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (brownstone research stock). Losing two months of production and sales actually affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million units is exceptional. More importantly, the hold-ups caused by the pandemic developed a lots of suppressed need. And that need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown 1 biotech company. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its three various stages.
In Stage Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services start to be used (korean actress). That's when we start to see applications running on 5G networks. Believe of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summertime. This starts something of a virtuous cycle: The majority of people don't really appreciate the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment chances moving forward will be massive. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR hereditary editing. CRISPR means "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a similar concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For several years, CRISPR was primarily a specific niche technology that wasn't well understood. And throughout that time, there were actually only 3 companies running in this space. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This whole market is successfully a greenfield opportunity.
There's space for numerous business to exist in this space. jeff brown genetic sequencer stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is very important because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced utilizing this technology. This was one of those breakthroughs that practically nobody discovered. However it's going to have profound ramifications for treating illness. And, obviously, there will be lots of investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps considerably prior to going greater. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - social media. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown prediction. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date since February 2021, however we might not separately validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an excellent point of view on the marketplace. He's always on the hunt for new chances, and he shares a lot of his finest choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he successfully forecasted a few of the most significant financial events of the previous 20 years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's precise forecasts have earned him legions of devoted followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research study offers several research study services with a wide array of expertises - tech stocks.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - future report. On its site, Brownstone says its mission is to supply retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been readily available to private financiers. It has been normally scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. tech stock. The mission of Brownstone Research study is to make that type of exclusive research offered to any investors looking to get an edge in the markets. The goal is easy to deliver unique and lucrative investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a bit about the marketplace, you understand that he has a track record as a King Midas of sorts. angel investor. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. tech stock. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 innovative innovations: expert system and electrical automobiles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars ever. It's nothing short of the automotive industry's Holy Grail. As you know, electrical cars and self-driving car stocks have been substantial this year, but the Wall Street device has actually been big on buzz without much concrete outcome. Regardless of an extreme increase in competition over the previous couple of years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Car, and it could be the future of transport. Basically, this innovation would permit you to lease your car as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the profits. It sounds crazy, but it could be closed than you think.